SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347942
Filing Date
2012-08-09
Accepted
2012-08-09 17:17:01
Documents
14
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d334181d10q.htm 10-Q 296664
2 EX-10.24.1 d334181dex10241.htm EX-10.24.1 77745
3 EX-10.25.1 d334181dex10251.htm EX-10.25.1 13203
4 EX-10.25.2 d334181dex10252.htm EX-10.25.2 17316
5 EX-31.1 d334181dex311.htm EX-31.1 10278
6 EX-31.2 d334181dex312.htm EX-31.2 10287
7 EX-32.1 d334181dex321.htm EX-32.1 4145
14 GRAPHIC g334181g95f55.jpg GRAPHIC 69919
  Complete submission text file 0001193125-12-347942.txt   2318475

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cpix-20120630.xml EX-101.INS 218410
9 XBRL TAXONOMY EXTENSION SCHEMA cpix-20120630.xsd EX-101.SCH 20669
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpix-20120630_cal.xml EX-101.CAL 38973
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpix-20120630_def.xml EX-101.DEF 41026
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpix-20120630_lab.xml EX-101.LAB 170073
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpix-20120630_pre.xml EX-101.PRE 124493
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 121021539
SIC: 2834 Pharmaceutical Preparations